Patient Satisfaction with Budesonide Turbuhaler™ Versus Triamcinolone Acetonide Administered via Pressurized Metered-Dose Inhaler in a Managed Care Setting

References

• Osman L. The patient perspective: what should a new anti-asthma agent provide?. Drugs 1996; 52(suppl 6):29–35. [CSA]
   PubMed Web of Science ®Google Scholar
• Kemp J P. Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma.Clin Ther 2003; 25(suppl C):C15–C27. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Horn C R, Clark T JH, Cochrane G M. Compliance with inhaled therapy and morbidity from asthma.Respir Med 1990; 84:67–70. [CSA]
   PubMed Web of Science ®Google Scholar
• Donahue J G, Weiss S T, Livingston J M, Goetsch M A, Greineder D K, Platt R. Inhaled steroids and the risk of hospitalization for asthma.JAMA 1997; 277:887–891. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma.N Engl J Med 2000; 343:332–336. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Markson L E, Vollmer W M, Fitterman L, O'Connor E, Narayanan S, Berger M, Buist A S. Insight into patient dissatisfaction with asthma treatment.Arch Intern Med 2001; 161:379–384. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics—2002.J Allergy Clin Immunol 2002; 110:S141–S219. [CSA]
   PubMedGoogle Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 1997, Available online at http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed June 27, 1999.
   Google Scholar
• Barnes P J, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma.Am Rev Respir Dis 1993; 148(4 pt 2):S1–S26. [CSA]
   PubMed Web of Science ®Google Scholar
• Pieters W R, Stallaert R ALM, Prins J, Greefherst A P, Bosman H G, van Uffelen R, Schreur A J, van Helmond J L, Janssen P G. A study on the clinical equivalence and patient preference of fluticasone propionate 250 µg twice daily via the Diskus™/Accuhaler™ Inhaler or the Diskhaler™ Inhaler in adult asthmatic patients.J Asthma 1998; 35:337–345., [CSA]
   PubMed Web of Science ®Google Scholar
• Boulet L P, Cowie R, Johnston P, Krakovsky D, Mark S. Comparison of Diskus™ Inhaler, a new multidose powder inhaler, with Diskhaler™ Inhaler for the delivery of salmeterol to asthmatic patients.J Asthma 1995; 32:429–436. [CSA]
   PubMed Web of Science ®Google Scholar
• Schlaeppi M, Edwards K, Fuller R W, Sharma R. Patient perception of the Diskus Inhaler: comparison with the Turbuhaler Inhaler.Br J Clin Pract 1996; 50:14–19. [CSA]
   PubMedGoogle Scholar
• van der Palen J, Klein J J, Schildkamp A M. Comparison of a new multidose powder inhaler (Diskus®/Accuhaler®) and the Turbuhaler® regarding preference and ease of use.J Asthma 1998; 35:147–152. [CSA]
   PubMed Web of Science ®Google Scholar
• Williams J, Richards K A. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus™ Inhaler compared with the Turbohaler™ Inhaler in paediatric patients.Br J Clin Pract 1997; 51:147–153. [CSA]
   PubMedGoogle Scholar
• Gioulekas D, Papakosta D, Vordoyianni P, Baloti H, Vamvalis C. A comparison of the clinical efficacy and patient acceptability of terbutaline turbuhaler and salbutamol rotahaler, in adult patients with asthma.Respir Med 1996; 90:205–209. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kesten S, Elias M, Cartier A, Chapman K R. Patient handling of a multidose dry powder inhalation device for albuterol.Chest 1994; 105:1077–1081. [CSA]
   PubMed Web of Science ®Google Scholar
• Boe J, Stiksa G, Svensson K, Asbrink E. New method of evaluating patient preference for different inhalation delivery systems.Ann Allergy 1992; 68:255–260. [CSA]
   PubMedGoogle Scholar
• Nielsen K, Okamoto L, Shah T. Importance of selected inhaler characteristics and acceptance of a new breath-actuated powder inhalation device.J Asthma 1997; 34:249–253. [CSA]
   PubMed Web of Science ®Google Scholar
• van Schayck C P, Bijl-Hofland I D, Folgering H, Cloosterman S G, Akkermans R, van den Elshout F, van Weel C. Influence of two different inhalation devices on therapy compliance in asthmatic patients.Scand J Prim Health Care 2002; 20:126–128. [CSA]
   PubMed Web of Science ®Google Scholar
• Tukiainen H, on behalf of the Finnish Study Group, Rytilä P, Hämäläinen K M, Silvasti M SL, Keski-Karhu J. Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients.Respir Med 2002; 96:221–229. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weiss K B, Liljas B, Schoenwetter W, Schatz M, Luce B R. Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings.Clin Ther 2004; 26:102–114. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Revicki D A, Frank L. Pharmacoeconomic evaluation in the real world: effectiveness versus efficacy studies.Pharmacoeconomics 1999; 15:423–434. [CSA]
   PubMed Web of Science ®Google Scholar
• Simon G E, VonKorff M, Heiligenstein J H, Revicki D A, Grothaus L, Katon W, Wagner E H. Initial antidepressant choice in primary care: effectiveness and dost of fluoxetine vs. tricyclic antidepressants.JAMA 1996; 275:1897–1902. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sullivan S, Elixhauser A, Buist A S, Luce B R, Eisenberg J, Weiss K B. National Asthma Education and Prevention Program Working Group report on the cost-effectiveness of asthma care.Am J Respir Crit Care Med 1996; 154(3 pt 2):S84–S95. [CSA]
   PubMed Web of Science ®Google Scholar
• Ware J E, Sherbourne C D. The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection.Med Care 1992; 30:473–483. [CSA]
   PubMed Web of Science ®Google Scholar
• Ware J, Kosinski M, Keller S D. SF-36 Physical and Mental Component Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
   Google Scholar
• Juniper E F, Guyatt G H, Epstein R S, Ferrie P J, Jaeschke R, Hiller T K. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax 1992; 47:76–83. [CSA]
   PubMed Web of Science ®Google Scholar
• Cramer J A, Spilker B. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991.
   Google Scholar
• Rand C S, Wise R A. Adherence with asthma therapy in the management of asthma. In: Szefler S, Leung D, eds. Severe Asthma: Pathogenesis and Clinical Management. New York: Marcel Dekker, 1995:435–464.
   Google Scholar
• Cronbach L J. Coefficient alpha and the internal structure of tests.Psychometrika 1951; 16:297–334. [CSA]
   Web of Science ®Google Scholar
• Jaeschke R, Singer J, Guyatt G H. Measurements of health status: ascertaining the minimal clinically important difference.Control Clin Trials 1989; 10:407–415. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Juniper E F, Guyatt G H, Willan A, Griffith L E. Determining a minimal important change in a disease-specific quality of life questionnaire.J Clin Epidemiol 1994; 47:81–87. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Revicki D A, Leidy N K, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the Multiattribute Asthma Symptom Utility Index.Chest 1998; 114:998–1007. [CSA]
   PubMed Web of Science ®Google Scholar
• American Association of Health Plans HMO and PPO Trends Report. Available online at: http://www.aahp.org/services/research_library/research/0613rep.html. Accessed October 4, 1999.
   Google Scholar
• Weaver M, Patrick D L, Markson L E, Martin D, Frederic I, Berger M. Issues in the measurement of satisfaction with treatment.Am J Manag Care 1997; 3:579–594. [CSA]
   PubMed Web of Science ®Google Scholar
• Campbell J L, Kiebert G M, Partridge M R. Development of the satisfaction with inhaled asthma treatment questionnaire.Eur Respir J 2003; 22:127–134. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar